[1]
|
Zhang, W., Mei, C., Chen, N., et al. (2019) Outcomes and Practice Patterns with Hemodiafiltration in Shanghai: A Lon-gitudinal Cohort Study. BMC Nephrology, 20, Article No. 34. https://doi.org/10.1186/s12882-019-1219-z
|
[2]
|
Cheung, A.K., Sarnak, M.J., Yan, G., et al. (2004) Cardiac Dis-eases in Maintenance Hemodialysis Patients: Results of the HEMO Study. Kidney International, 65, 2380-2389. https://doi.org/10.1111/j.1523-1755.2004.00657.x
|
[3]
|
Farshid, A., Pathak, R., Shadbolt, B., Arnolda, L. and Ta-laulikar, G. (2013) Diastolic Function Is a Strong Predictor of Mortality in Patients with Chronic Kidney Disease. BMC Nephrology, 14, Article No. 280.
https://doi.org/10.1186/1471-2369-14-280
|
[4]
|
Bozkurt, B., Coats, A.J., Tsutsui, H., Abdelhamid, M., Adamopoulos, S., Albert, N., Anker, S.D., Atherton, J., Böhm, M., Butler, J., Drazner, M.H., Felker, G.M., Filippatos, G., Fonarow, G.C., Fiuzat, M., Gomez-Mesa, J.E., Heidenreich, P., Imamura, T., Januzzi, J., Jankowska, E.A., Khazanie, P., Kinugawa, K., Lam, C.S.P., Matsue, Y., Metra, M., Ohtani, T., Francesco, P.M., Ponikowski, P., Rosano, G.M.C., Sakata, Y., Seferovi, Ć.P., Starling, R.C., Teerlink, J.R., Vardeny, O., Yamamoto, K., Yancy, C., Zhang, J. and Zieroth, S. (2021) Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Journal of Cardiac Failure. https://doi.org/10.1002/ejhf.2115
|
[5]
|
Pecoits-Filho, R., Bucharies, S. and Barberato, S.H. (2012) Diastolic Heart Failure in Dialysis Patients: Mechanisms, Diagnostic Approach, and Treatment. Seminars in Dialysis, 25, 35-41.
https://doi.org/10.1111/j.1525-139X.2011.01011.x
|
[6]
|
Chawla, L.S., Herzog, C.A., Costanzo, M.R., et al. (2014) Proposal for a Functional Classification System of Heart Failure in Patients with End-Stage Renal Disease. Proceedings of the Acute Dialysis Quality Initiative (ADQI) XI Workgroup. Journal of the American College of Cardiology, 63, 1246-1252. https://doi.org/10.1016/j.jacc.2014.01.020
|
[7]
|
Marlies, A., Stefan, A., Chantal, K., et al. (2017) Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis. Kidney and Blood Pressure Research, 42, 165-176.
https://doi.org/10.1159/000473868
|
[8]
|
Wang, J., Lv, J., He, K., et al. (2022) Association of Left Ventricular Hy-pertrophy and Functional Impairment with Cardiovascular Outcomes and Mortality among Patients with Chronic Kidney Disease, Results from the C-STRIDE Study. Nephrology (Carlton, Vic.), 27, 327-336. https://doi.org/10.1111/nep.14009
|
[9]
|
Meeus, F., Kourilsky, O., Guerin, A.P., et al. (2000) Pathophysiology of Cardiovascular Disease in Hemodialysis Patients. Kidney International. Supplement, 76, S140-S147. https://doi.org/10.1046/j.1523-1755.2000.07618.x
|
[10]
|
Tok, D., Gullu, H., Erdogan, D., et al. (2005) Impaired Coronary Flow Reserve in Hemodialysis Patients: A Transthoracic Doppler Echocardiographic Study. Nephron Clinical Practice, 101, c200-c206.
https://doi.org/10.1159/000087579
|
[11]
|
Redfield, M.M. (2016) Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine, 375, 1868-1877. https://doi.org/10.1056/NEJMcp1511175
|
[12]
|
Mori, K. (2021) Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Espe-cially Those Undergoing Hemodialysis. Nutrients, 13, 1538. https://doi.org/10.3390/nu13051538
|
[13]
|
Escoli, R., Carvalho, M.J., Cabrita, A., et al. (2019) Diastolic Dysfunction, an Underestimated New Challenge in Dialysis. Thera-peutic Apheresis and Dialysis, 23, 108-117. https://doi.org/10.1111/1744-9987.12756
|
[14]
|
Stewart Coats, A.J. (2019) Common Co-Morbidities in Heart Failure—Diabetes, Functional Mitral Regurgitation and Sleep Apnoea. Interna-tional Journal of Heart Failure, 1, 25-41. https://doi.org/10.36628/ijhf.2019.0004
|
[15]
|
Oleśkowska-Florek, W., Połubinska, A., Baum, E., Matecka, M., Pyda, M., Pawlaczyk, K. and Bręborowicz, A. (2014) Hemodialysis-Induced Changes in the Blood Composition Affect Function of the Endothelium. Hemodialysis International, 18, 650-656. https://doi.org/10.1111/hdi.12148
|
[16]
|
Md, M.A., et al. (2022) Skeletal Muscle Abnormalities in Heart Failure with Preserved Ejection Fraction. Heart Failure Reviews. https://doi.org/10.1007/s10741-022-10219-9
|
[17]
|
Youn, J.C., Choi, S.W., Lee, H.S., Han, S., Shin, E., Baek, S.H. and Kang, S.M. (2021) Prognostic Value of Leg Muscle Strength in Acute Heart Failure Syndrome. Medicine & Science in Sports & Exercise, 53, 19-25.
https://doi.org/10.1249/MSS.0000000000002432
|
[18]
|
Rroji, M., Cafka, M., Seferi, S., et al. (2021) The Potential Effect of Cardiac Function on Pulmonary Hypertension, Other Risk Factors, and Its Impact on Survival in Dialysis Pa-tients. International Urology and Nephrology, 53, 343-351.
https://doi.org/10.1007/s11255-020-02655-z
|
[19]
|
Paulus, W.J., Tschope, C., Sanderson, J.E., Rusconi, C., Flach-skampf, F.A., Rade-makers, F.E., Marino, P., Smiseth, O.A., De Keulenaer, G., Leite-Moreira, A.F., Borbely, A., Edes, I., Handoko, M.L., Heymans, S., Pezzali, N., Pieske, B., Dickstein, K., Fraser, A.G. and Brutsaert, D.L. (2007) How to Diagnose Diastolic Heart Failure: A Consensus Statement on the Diagnosis of Heart Failure with Normal Left Ventricu-lar Ejection Fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. European Heart Journal, 28, 2539-2550.
https://doi.org/10.1093/eurheartj/ehm037
|
[20]
|
Nagueh, S.F., Appleton, C.P., Gillebert, T.C., Marino, P.N., Oh, J.K., Smiseth, O.A., Waggoner, A.D., Flachskampf, F.A., Pellikka, P.A. and Evangelista, A. (2009) Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. Journal of the American Society of Echo-cardiography, 22, 107-133.
https://doi.org/10.1016/j.echo.2008.11.023
|
[21]
|
McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A. and ESC Committee for Practice Guidelines (CPG) (2012) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in Collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787-1847. https://doi.org/10.1093/eurjhf/hft016
|
[22]
|
De Filippi, C.R. and Herzog, C.A. (2017) Interpreting Cardiac Bi-omarkers in the Setting of Chronic Kidney Disease. Clinical Chemistry, 63, 59-65. https://doi.org/10.1373/clinchem.2016.254748
|
[23]
|
Jafri, L., Kashif, W., Tai, J., et al. (2013) B-Type Natriuretic Peptide versus Amino Terminal pro-B Type Natriuretic Peptide: Selecting the Optimal Heart Failure Marker in Patients with Impaired Kidney Function. BMC Nephrology, 14, Article No. 117. https://doi.org/10.1186/1471-2369-14-117
|
[24]
|
Eriguchi, M., et al. (2022) Routinely Measured Cardiac Troponin I and N-terminal pro-B-type Natriuretic Peptide as Predictors of Mortality in Haemodialysis Patients. ESC Heart Failure, 9, 1138-1151.
https://doi.org/10.1002/ehf2.13784
|
[25]
|
Collister, D., Mazzetti, A., Bhalerao, A., et al. (2020) Variability in Cardiac Biomarkers during Hemodialysis: A Prospective Cohort Study. Clinical Chemistry, 67, 308-316. https://doi.org/10.1093/clinchem/hvaa299
|
[26]
|
Sun, L., Ji, Y., Wang, Y., Ding, M., Xie, X., Zhu, D., Chen, F., Zhang, N. and Wang, X. (2018) High-Sensitive Cardiac Troponin T: A Biomarker of Left-Ventricular Diastolic Dys-function in Hemodialysis Patients. Journal of Nephrology, 31, 967-973. https://doi.org/10.1007/s40620-018-0540-0
|
[27]
|
Sherif, F., Nagueh, O.A., et al. (2016) Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echo-cardiography and the European Association of Cardiovascular Imaging. European Heart Journal Cardiovascular Imag-ing, 17, 1321-1360.
|
[28]
|
Marwick, T.H. (2015) The Role of Echocardiography in Heart Failure. Journal of Nuclear Medicine, 56, 31S-38S.
https://doi.org/10.2967/jnumed.114.150433
|
[29]
|
Pecoits-Filho, R. and Ba Rberato, S.H. (2010) Echocardiography in Chronic Kidney Disease: Diagnostic and Prognostic Implications. Nephron Clinical Practice, 114, c242-c247. https://doi.org/10.1159/000276575
|
[30]
|
Huang, J.-C., et al. (2019) Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate and Global Left Ventricular Longitudinal Systolic Strain Predict Overall Mortality and Major Adverse Cardiovascular Events in Hemodialysis Patients. Disease Markers, 2019, Article ID: 7512805. https://doi.org/10.1155/2019/7512805
|
[31]
|
Sinha, A.D. and Agarwal, R. (2017) Setting the Dry Weight and Its Cardiovascular Implications. Seminars in Dialysis, 30, 481-488. https://doi.org/10.1111/sdi.12624
|
[32]
|
Puntoni, A., Giannese, D., Varricchio, E., et al. (2020) Different Methods to Manage Dry Weight in Hemodialysis Patients. Giornale Italiano di Nefrologia, 37, 2020-vol1.
|
[33]
|
Tsilonis, K., Sarafidis, P.A., Kamperidis, V., Loutradis, C., Georgianos, P.I., Imprialos, K., et al. (2016) Echocardiographic Parameters during Long and Short Interdialytic Intervals in Hemodialysis Patients. American Journal of Kidney Diseases, 68, 772-781. https://doi.org/10.1053/j.ajkd.2016.06.017
|
[34]
|
Braunschweig, F., Kjellström, B., Söderhäll, M., Clyne, N. and Linde, C. (2006) Dynamic Changes in Right Ventricular Pressures during Haemodialysis Recorded with an Implantable Haemodynamic Monitor. Nephrology Dialysis Transplantation, 21, 176-183. https://doi.org/10.1093/ndt/gfi145
|
[35]
|
Jefferies, H.J., Virk, B., Schiller, B., et al. (2011) Frequent Hemodialysis Schedules Are Associated with Reduced Levels of Dialysis-Induced Cardiac Injury (Myocardial Stunning). Clinical Journal of the American Society of Nephrology, 6, 1326. https://doi.org/10.2215/CJN.05200610
|
[36]
|
Valerianova, A., et al. (2021) Reduction of Arteriovenous Access Blood Flow Leads to Biventricular Unloading in Haemodialysis Pa-tients. International Journal of Cardiology, 334, 148-153.
https://doi.org/10.1016/j.ijcard.2021.04.027
|
[37]
|
Solomon, S.D., Appelbaum, E., Manning, W.J., et al. (2009) Ef-fect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients with Hypertension and Left Ventricular Hypertrophy. Circulation, 119, 530-537. https://doi.org/10.1161/CIRCULATIONAHA.108.826214
|
[38]
|
Agarwal, A. and Cheung, A.K. (2020) Mineralo-corticoid Receptor Antagonists in ESKD. Clinical Journal of the American Society of Nephrology, 15, 1047-1049. https://doi.org/10.2215/CJN.13221019
|
[39]
|
Habibi, J., Demarco, V.G., Ma, L., et al. (2011) Mineralocorticoid Receptor Blockade Improves Diastolic Function Independent of Blood Pressure Reduction in a Transgenic Model of RAAS Overexpression. American Journal of Physiology-Heart and Circulatory Physiology, 300, H1484. https://doi.org/10.1152/ajpheart.01000.2010
|
[40]
|
Hauser, T., Dornberger, V., Malzahn, U., et al. (2021) The Effect of Spironolactone on Diastolic Function in Haemodialysis Patients. The International Journal of Cardiovascular Imag-ing, 37, 1927-1936.
https://doi.org/10.1007/s10554-021-02176-5
|
[41]
|
Rico-Mesa, J.S., White, A., Ahmadian-Tehrani, A., et al. (2020) Mineralocorticoid Receptor Antagonists: A Comprehensive Review of Finerenone. Current Cardiology Reports, 22, 140. https://doi.org/10.1007/s11886-020-01399-7
|
[42]
|
Grune, J., Beyhoff, N., Smeir, E., et al. (2018) Selective Miner-alocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone’s Antifibrotic Activity. Hypertension, 71, 599-608.
https://doi.org/10.1161/HYPERTENSIONAHA.117.10360
|
[43]
|
Ortiz, A., et al. (2021) Mineralocorticoid Recep-tor Antagonists for Nephroprotection and Cardioprotection in Patients with Diabetes Mellitus and Chronic Kidney Dis-ease. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Associa-tion-European Renal Association.
https://doi.org/10.1093/ndt/gfab167
|
[44]
|
Zhang, X., Zhou, Y. and Ma, R. (2021) Potential Effects and Application Prospect of Angiotensin Receptor-Neprilysin Inhibitor in Diabetic Kidney Disease. Journal of Diabetes and Its Compli-cations, 36, Article ID: 108056.
https://doi.org/10.1016/j.jdiacomp.2021.108056
|
[45]
|
Alawi, L.F., et al. (2020) Effect of Hyperglycemia and Rosig-litazone on Renal and Urinary Neprilysin in db/db Diabetic Mice. Physiological Reports, 8, e14364.
|
[46]
|
Tersalvi, G., Dauw, J., Martens, P., et al. (2020) Impact of Sacubitril-Valsartan on Markers of Glomerular Function. Current Heart Failure Reports, 17, 145-152. https://doi.org/10.1007/s11897-020-00463-1
|
[47]
|
Solomon, S.D., Zile, M., Pieske, B., et al. (2012) The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Frac-tion: A Phase 2 Double-Blind Randomised Controlled Trial. The Lancet, 380, 1387-1395. https://doi.org/10.1016/S0140-6736(12)61227-6
|
[48]
|
Solomon, S.D., Mcmurray, J., Anand, I.S., et al. (2019) An-giotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine, 381, 1609-1620.
|
[49]
|
Yang, L., Ye, N., Bian, W. and Cheng, H. (2021) Efficacy of Medication Therapy for Patients with Chronic Kidney Disease and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. International Urology and Nephrology, 381, 1609-1620. https://doi.org/10.1007/s11255-021-03025-z
|
[50]
|
van der Aart-van der Beek, A.B., de Boer, R.A. and Heerspink, H.J.L. (2022) Kidney and Heart Failure Outcomes Associated with SGLT2 Inhibitor Use. Nature Reviews Nephrology, 18, 294-306.
https://doi.org/10.1038/s41581-022-00535-6
|
[51]
|
Lo, C., Fei, Y. and Cheung, B. (2021) Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes. Cardiac Failure Review, 7, e04. https://doi.org/10.15420/cfr.2020.19
|
[52]
|
Achinger, S.G. and Ayus, J.C. (2005) The Role of Vitamin D in Left Ventricular Hypertrophy and Cardiac Function. Kidney International Supplements, 67, S37-S42. https://doi.org/10.1111/j.1523-1755.2005.09506.x
|
[53]
|
Ahmadmehrabi, S. and Tang, W. (2018) Hemodialy-sis-Induced Cardiovascular Disease. Seminars in Dialysis, 31, 258-267. https://doi.org/10.1111/sdi.12694
|
[54]
|
Teng, M. (2005) Activated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study. Journal of the American Society of Nephrology, 16, 1115-1125. https://doi.org/10.1681/ASN.2004070573
|
[55]
|
Park, C.W., Yong, S.O., Shin, Y.S., et al. (1999) Intravenous Cal-citriol Regresses Myocardial Hypertrophy in Hemodialysis Patients with Secondary Hyperparathyroidism. American Journal of Kidney Diseases, 33, 73-81.
https://doi.org/10.1016/S0272-6386(99)70260-X
|
[56]
|
Laclair, R.E., Hellman, R.N., Karp, S.L., et al. (2005) Prev-alence of Calcidiol Deficiency in CKD: A Cross-Sectional Study across Latitudes in the United States. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 45, 1119-1121. https://doi.org/10.1053/j.ajkd.2005.02.029
|
[57]
|
Hwang, J.H., Park, J.B., Kim, Y.J., et al. (2017) The Prognostic Significance of Preoperative Left Ventricular Diastolic Dysfunction and Left Atrial Enlargement on Acute Coronary Syn-drome in Kidney Transplantation. Oncotarget, 8, 71154-71163. https://doi.org/10.18632/oncotarget.16862
|